Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of BG136 in advanced colorectal cancer
CTR20251211Phase 2Completed
- Sponsor
- Qingdao Marine Biomedical Research Institute
- Start
- Apr 2025
- Countries
- 1
01
Overview
A Phase 2 trial of BG136 in colorectal cancer (CRC), sponsored by Qingdao Marine Biomedical Research Institute. Started Apr 2025; status: completed.
02
Drugs
BG136
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20251211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251211.